BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17461700)

  • 1. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.
    Yoon SJ; Ho J; Kang HY; Lee SH; Kim KI; Shin WG; Oh JM
    Pharmacotherapy; 2007 May; 27(5):657-65. PubMed ID: 17461700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study.
    Childers MK; Wilson DJ; Gnatz SM; Conway RR; Sherman AK
    Am J Phys Med Rehabil; 2002 Oct; 81(10):751-9. PubMed ID: 12362115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piriformis syndrome: pain response outcomes following CT-guided injection and incremental value of botulinum toxin injection.
    Yan K; Xi Y; Hlis R; Chhabra A
    Diagn Interv Radiol; 2021 Jan; 27(1):126-133. PubMed ID: 33252337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study.
    Fishman LM; Konnoth C; Rozner B
    Am J Phys Med Rehabil; 2004 Jan; 83(1):42-50; quiz 51-3. PubMed ID: 14709974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
    Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B in piriformis syndrome.
    Lang AM
    Am J Phys Med Rehabil; 2004 Mar; 83(3):198-202. PubMed ID: 15043354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of piriformis injection on neuropathic pain.
    Terlemez R; Erçalık T
    Agri; 2019 Nov; 31(4):178-182. PubMed ID: 31741344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial.
    Najafi S; Sanati E; Khademi M; Abdorrazaghi F; Mofrad RK; Rezasoltani Z
    Toxicon; 2019 Jul; 165():69-77. PubMed ID: 30995453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve Block Guided by Anatomic Landmarks Only Reduces Pain in Botulinum Toxin Type A Treatment for Glabellar and Forehead Wrinkles.
    Chen C; Zhou L; Li F; Pei H
    Ann Plast Surg; 2024 May; 92(5):508-513. PubMed ID: 38685490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of botulinum toxin type A treatment of functional impairment of degenerative hip joint: Preliminary results.
    Marchini C; Acler M; Bolognari MA; Causero A; Volpe D; Regis D; Rizzo A; Rosa R; Eleopra R; Manganotti P
    J Rehabil Med; 2010 Jul; 42(7):691-3. PubMed ID: 20603701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Ultrasound-Guided Injection of Botulinum Toxin, Ozone, and Lidocaine in Piriformis Syndrome.
    Elsawy AGS; Ameer AH; Gazar YA; Allam AE; Chan SM; Chen SY; Hou JD; Tai YT; Lin JA; Galluccio F; Nada DW; Esmat A
    Healthcare (Basel); 2022 Dec; 11(1):. PubMed ID: 36611554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local botulinum toxin type A injections in the treatment of spastic toes.
    Suputtitada A
    Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
    Nicol AL; Wu II; Ferrante FM
    Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.